High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancerGuoliang Wang, Cheng Liu, Yi Huang et al.|Aging|2020Cited by 32
TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significanceTiantian Liu, Dawei Xu, Chuanyou Xia et al.|Frontiers in Immunology|2023Cited by 21